Sarepta Announces FDA’s Approval of Updated ELEVIDYS Prescribing Information
Go back to Sarepta Announces FDA’s Approval of Updated ELEVIDYS Prescribing Information| SAREPTA THERAP (NASDAQ: SRPT) | Delayed: 18.92 --0 (-0%) | |||||
|---|---|---|---|---|---|---|
| Previous Close | $18.92 | 52 Week High | $63.73 | |||
| Open | $18.92 | 52 Week Low | $8.00 | |||
| Day High | $18.92 | P/E | N/A | |||
| Day Low | $18.92 | EPS | $-5.69 | |||
| Volume | 104 | |||||
